Smartlab Europe

Drug Research

Potential Target Identified To Combat Blood Cancer – Study

A worldwide consortium that comprises biomedical researchers co-led by Alexander Bick, MD, PhD, at the Vanderbilt University Medical Centre, has come up with a new way to gauge the precancerous clones of blood stem cells that would go on...

Bora Pharmaceuticals and Celltrion partner to expand OSD capabilities in the APAC market

Bora Pharmaceuticals Co., Ltd. and Celltrion Asia Pacific Pte., Ltd. , a subsidiary of Celltrion Group Inc, have announced their partnership to contract manufacture and commercialize a range of oral dosage form drugs (OSD) across the APAC region. The range...

Better Effect If Customised Blood Pressure Treatment Taken

A study from Sweden has gone on to show that patients who have been treated with drugs that are used to lower blood pressure can get better results after changing medications as compared to doubling the dosage of their...

Patient Blood Cells Get Rid of Tumour Through New Therapy

Adoptive cell therapy has gone on to become a promising immunotherapy tool that can be used to help in the treatment of advanced melanoma. The therapy, which makes use of the immune cells that are collected from the individual's...

New MRI Method Aids In Cell-Energy In Tissues And Organs

Each cell in the body puts in considerable energy to maintain the proper balance of water and critical electrolytes in order to survive. Researchers at Oregon Health & Science University (OHSU) have gone on to develop a way for...

Monoclonal Antibodies Help COVID – 19 Hospitalisation To Dip

A study has gone on to find that monoclonal antibodies (mAbs) decreased the risk of hospitalisation or even death by 39% if given within two days to people who are tested positive for COVID-19. The research compared the patients who...

New Antibiotic Discovery Helped By Australia Sepsis Study

Researchers from the University of Queensland in Australia have led a national study pertaining to four major bacteria that cause sepsis, thereby providing new targets when it comes to developing antibiotics. Professor Mark Schembri and Professor Mark Walker from the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »